[1] Cheng J, Liu JJ. Current status and progress of surveillance and automated-alert for tuberculosis in school. Chin J Antituberc 2020;42(5):436 − 41. https://doi.org/10.3969/j.issn.1000-6621.2020.05.005.
[2] Chen H, Xia YY, Zhang CY, Cheng J, Zhang H. Epidemic trends and characteristics of pulmonary tuberculosis in students in China from 2014 to 2018. Chin J Antituberc 2019;41(6):662 − 8. https://doi.org/10.3969/j.issn.1000-6621.2019.06.013.
[3] Gegia M, Winters N, Benedetti A, van Soolingen D, Menzies D. Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis. Lancet Infect Dis 2017;17(2):223 − 34. https://doi.org/10.1016/S1473-3099(16)30407-8.
[4] Nikolayevskyy V, Niemann S, Anthony R, van Soolingen D, Tagliani E, Ködmön C, et al. Role and value of whole genome sequencing in studying tuberculosis transmission. Clin Microbiol Infect 2019;25(11):1377 − 82. https://doi.org/10.1016/j.cmi.2019.03.022.
[5] Yin XW, Zhang Q, Wang YT, Tao BL, Zhang XL, Shi JY, et al. Genomic and spatial analysis on the recent transmission of Mycobacterium tuberculosis in eastern China: a 10-year retrospective population-based study. Infect Drug Resist 2024;17:4257 − 69. https://doi.org/10.2147/IDR.S480621.
[6] Nikolayevskyy V, Kranzer K, Niemann S, Drobniewski F. Whole genome sequencing of Mycobacterium tuberculosis for detection of recent transmission and tracing outbreaks: a systematic review. Tuberculosis 2016;98:77 − 85. https://doi.org/10.1016/j.tube.2016.02.009.
[7] WHO. Guidelines Approved by the Guidelines Review Committee. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva: World Health Organization, 2018. https://www.who.int/publications/i/item/9789241550239.